ADVERTISEMENT
While no one expects cannabis to overshadow the action on the field, many foresee at least a marginal lift in pot sales and dispensary foot traffic when Toronto and Vancouver play host for their combined 13 matches in June and July.
U.S. President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry: It gives dispensaries a big tax break, eases some barriers to researching cannabis and could even allow the export of marijuana to other countries.
The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers adjust product offerings to suit changing consumer behaviour tied to the therapies.
U.S. President Donald Trump on Thursday signed an order recommending the loosening of federal regulations on marijuana, a move that could further reverse decades of tough-on-weed policy.
U.S. President Donald Trump is expected to sign an executive order on Thursday reclassifying marijuana to ease federal restrictions, according to CNN, which cited a source familiar with the planning and a senior White House official.
Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's arrangement agreement to acquire MTL Cannabis.
Canopy Growth Corp. has signed a deal to buy Quebec-based MTL Cannabis Corp. in a transaction valued at about $125 million
Dan Ahrens, managing director, chief operating officer, and portfolio manager at Advisor Shares, joins BNN Bloomberg to discuss the outlook on cannabis stocks.
Shares in Canada’s cannabis companies surged after reports U.S. President Donald Trump is planning to ease federal restrictions on the drug.
Vahan Ajamian, capital markets analyst at High Tide Inc., joins BNN Bloomberg to discuss cannabis stocks amid U.S. reclassification and what that could mean.
Raj Grover, Founder and Chief Executive Officer of High Tide, joins BNN Bloomberg to discuss the company's expansion into the German medical cannabis market.
Beena Goldenberg, CEO of Organigram Global, joins BNN Bloomberg to discuss the company's acquisition of Motif as their outlook for the future.
Shares of pot companies jumped on Monday after U.S. President Donald Trump said his administration is looking at reclassifying marijuana as a less dangerous drug, potentially easing criminal penalties and reshaping the industry’s federal standing.
Miguel Martin, CEO of Aurora Cannabis, joins BNN Bloomberg to discuss the company's Q1 earnings.
One of the largest cannabis players in Canada keeps growing and growing.
Top alcohol makers have been sitting on the sidelines of a cannabis beverage boom, watching brands make deals with beer and booze distributors.
